Patent application number | Description | Published |
20090164935 | SYMBOL LISTS FOR GRAMMAR-DRIVEN DATA ENTRY - In a data entry environment constrained by a symbolic grammar, a data entry position in the data set may be amenable to the insertion of a subset of symbols in compliance with the grammar. Also, the grammar may or may not permit the insertion of a value of one or more types at the data entry position of the data set. In order to facilitate grammatically correct data entry, a symbol list may be presented that indicates the grammatically valid symbols for the symbolic context of the data entry position, as well as the validity of the insertion of a value at the data entry position. The symbol list may also permit the selection of a symbol list option, and may insert the selected symbol or value at the data entry position. Various symbol list option selection inputs may be associated with the symbol list options to facilitate and economize data entry, and the association may be adapted based on whether or not a value is permitted at the data entry position. Several variations of these techniques are discussed relating to the use of symbol lists in various data entry and grammar scenarios, the presentation of the symbol lists, and the user interaction with the symbol lists. | 06-25-2009 |
20130054923 | AUTOMATIC MEMORY LEAK DETECTION - Memory leak detection can be automated by assigning and recording an increasing sequence number to each memory allocation requested by an action. Call stacks associated with the action are also recorded. Several repetitions of the action can be executed. Allocations that occur in each action and that have similar or matching callstacks are defined as leaks. Allocations that do not have matches can be ignored. | 02-28-2013 |
20130054925 | MEMORY ALLOCATION TRACKING - The subject disclosure relates to tracking and/or auditing memory allocations for one or more computer-implemented processes. In particular, memory allocation commands as well as memory free commands, both native and managed, can be intercepted. As such, a tag can be created that can be associated with a particular memory allocation. This tag can include various information that can more robustly describe the current state of system memory. Moreover, the tag can be deleted as an associated memory free command is received. Thus, as memory is freed and therefore no longer relevant to the current state of system memory, such does not clutter present examination. | 02-28-2013 |
20130054926 | MEMORY ALLOCATION ANALYSIS - The subject disclosure relates to analyzing memory allocations for one or more computer-implemented processes. In particular, in conjunction with employing tags for tracking memory allocation commands, currently allocated memory can be examined for various characteristics of inefficient memory use. For example, as memory is initially allocated, a predetermined bit pattern can be written to the newly allocated memory. Thus, detection of the predetermined bit pattern can be indicative of wasted memory use. Moreover, additional features can be provided to both analyze data and present views associated with that analysis relating to identification of memory fragmentation, over-allocation, sparse memory use, duplication of allocations, multiple module loads, and so forth. | 02-28-2013 |
20150032985 | MEMORY ALLOCATION ANALYSIS - The subject disclosure relates to analyzing memory allocations for one or more computer-implemented processes. In particular, in conjunction with employing tags for tracking memory allocation commands, currently allocated memory can be examined for various characteristics of inefficient memory use. For example, as memory is initially allocated, a predetermined bit pattern can be written to the newly allocated memory. Thus, detection of the predetermined bit pattern can be indicative of wasted memory use. Moreover, additional features can be provided to both analyze data and present views associated with that analysis relating to identification of memory fragmentation, over-allocation, sparse memory use, duplication of allocations, multiple module loads, and so forth. | 01-29-2015 |
Patent application number | Description | Published |
20140104824 | Linear Solid-State Lighting With Degenerate Voltage Sensing Free Of Fire And Shock Hazards - A linear light-emitting diode (LED)-based solid-state universal lamp using a degenerate voltage sensing and control mechanism operates normally in both single-ended and double-ended linear tube lamp fixtures. The degenerate voltage sensing and control mechanism automatically detects power source configuration in the fixture and makes proper management so that the universal lamp works in any fixtures without operational uncertainty or risk of fire. When used with shock protection switches in the two lamp bases at two opposite ends, the universal lamp fully protects a person from possible electric shock during initial installation and re-lamping. | 04-17-2014 |
20140340884 | LINEAR SOLID-STATE LIGHTING WITH READILY RETROFITTABLE MODULAR STRUCTURE - A linear light-emitting diode (LED) tube lamp having a readily retrofittable modular structure enables consumers or manufacturers to readily retrofit the lamp by replacing an LED module or internal electronic control units that include an LED driver in maintenance or lamp upgrade without hazards. The readily retrofittable modular structure includes a core assembly in each of lamp bases for easily securing or removing the electronic control unit through a mechanical securing means, and two sets of connection modules for quickly connecting and disconnecting the electronic control unit with the LED module. The readily retrofittable modular structure may use one bi-pin or two bi-pins to connect to the AC mains via pluggable wire for delivering power to the LEDs. Thus, the LLT lamp using the readily retrofittable modular structure may be configured as single-ended, double-ended, or double-ended with double shock-protection switches and can be cost-effectively retrofitted after initial installation. | 11-20-2014 |
20150049476 | SOLID-STATE LIGHTING TROFFER WITH READILY RETROFITTABLE STRUCTURE - A light-emitting diode (LED) troffer adopts LED light sources mounted along two lengthwise sides of an LED module that uses a reflecting diffuser and a diffused light exit window to sufficiently average white light emissions from a plurality of LEDs or to properly mix light emissions from white LEDs at correlated color temperature (CCT) of 6,200±300 K with emissions from LEDs having saturated colors for uniform and tunable CCT light outputs having a consistent intensity or color hue within viewing angles. The troffer adopting a retrofittable design enables single person to readily hang and secure the LED module single-ended on top of the troffer for installation, retrofit, and inspection. The troffer uses such an integrated LED module with a power density less than 0.0127 W/cm | 02-19-2015 |
20150061542 | Linear Solid-State Lighting With Ballast Free Of Electric Shock Hazard - A linear light-emitting diode (LED)-based solid-state lamp using an AC current control scheme and shock protection switches operates normally with an electronic ballast. Due to the use of shock protection switches in the two lamp bases at two opposite ends, the ballast-compatible LED lamp fully protects a person from possible electric shock during initial installation, maintenance, and re-lamping no matter what the rated power and the brand of the LLT lamp are and no matter whether the electronic ballast is existing used ones that may be incompatible with the lamp or faulty, leading to an unacceptable leakage current. | 03-05-2015 |
Patent application number | Description | Published |
20080215040 | VARIABLE DEPTH SKIN HEATING WITH LASERS - Treating biological tissue can include selecting parameter for electromagnetic radiation based on at least one parameter of a target region within the biological tissue. Treating biological tissue also includes methods, systems, and kits for delivering the electromagnetic radiation through a surface of the biological tissue to the target region to induce within the target region a sub-surface thermal injury characterized, for example, by a desired degree and a desired depth and confining the sub-surface thermal injury to substantially within the target region. | 09-04-2008 |
20080221649 | Method of sequentially treating tissue - A treatment for deep tissue using long effective pulse durations is described. Fatty tissue can be treated by delivering a beam of radiation to a subcutaneous fat region disposed relative to a dermal interface in a target region of skin. Radiation is delivered to a first region of tissue as by exposure to pulses of the beam of radiation in a stacked fashion. Between successive exposures of the first region of tissue, other regions of tissue are exposed to the beam of radiation. | 09-11-2008 |
20080269733 | METHOD AND APPARATUS FOR TREATING WRINKLES IN SKIN USING RADIATION - A method for treating wrinkles in skin involves the use of a beam of pulsed, scanned or gated continuous wave laser or incoherent radiation. The method comprises generating a beam of radiation, directing the beam of radiation to a targeted dermal region between 100 microns and 1.2 millimeters below a wrinkle in the skin, and thermally injuring collagen in the targeted dermal region. The beam of radiation has a wavelength of between 1.3 and 1.8 microns. The method may include cooling an area of the skin above the targeted dermal region while partially denaturing the collagen in the targeted dermal region. The method may also include cooling an area of the skin above the targeted dermal region prior to thermally injuring collagen in the targeted dermal region. | 10-30-2008 |
20080269734 | Optical Array for Treating Biological Tissue - Skin can be treated by penetrating an epidermis of the skin with a plurality of waveguides. Each waveguide has an end, which is positioned within a dermis of the skin. Electromagnetic radiation can be delivered through the plurality of waveguides to the dermis having a port wine stain for a time sufficient to selectively destroy a cutaneous blood vessel within the port wine stain. The time is less than a thermal diffusion time between the epidermis and the dermis to prevent forming substantial unwanted thermal injury within the epidermis. | 10-30-2008 |
20080269735 | Optical array for treating biological tissue - An apparatus can treat biological tissue using a base member, a plurality of needles, and a plurality of fiber optics. The plurality of needles extend from the base member. Each needle defines a bore capable of receiving a fiber optic and has an end. The plurality of needles form an array capable of penetrating a biological tissue and positioning each end within a subsurface volume of the biological tissue. Each fiber optic is adapted for insertion into the bore of each needle, and each fiber optic is capable of delivering electromagnetic radiation to the subsurface volume of the biological tissue to treat the biological tissue. | 10-30-2008 |
20110015549 | METHOD AND APPARATUS FOR TREATING A DISEASED NAIL - A diseased nail is treated using electromagnetic radiation and/or other forms of energy that are applied to the diseased area to eliminate, substantially eliminate or effectively reduce the source of disease in the nail. A sensor can be used to ensure proper placement of an applicator that applies the energy to the diseased area of the nail. A temperature monitor can be employed to monitor changes or temperature levels and then adjust the energy application accordingly. In additional, manual forms of adjustment can be used to control the application of energy. | 01-20-2011 |
20120179227 | Reduction of Pain through Lower Fluence Rates and Longer treatment Times - A method of treating a subcutaneous fat region is provided. The method includes generating electromagnetic radiation having a wavelength of about 1,200 nm to about 1,230 nm and delivering an average power density of less than or equal to about 2.3 W/cm | 07-12-2012 |
20120310235 | TREATMENT OF SKIN BY SPATIAL MODULATION OF THERMAL HEATING - Treating skin can include delivering a beam of radiation to a target region of the skin to cause a zone of thermal injury including a lateral pattern of varying depths of thermal injury distributed along the target region. The lateral pattern includes at least one first sub-zone of a first depth of thermal injury laterally adjacent to at least one second sub-zone of a second depth of thermal injury. The first depth is greater than the second depth. The at least one first sub-zone of the first depth and the at least one second sub-zone of the second depth extend from a surface of the target region of the skin to form a substantially continuous surface thermal injury. The at least one first sub-zone of the first depth and the at least one second sub-zone of the second depth are substantially heated to at least a critical temperature. | 12-06-2012 |
20130072914 | Skin Resurfacing at 1930 NM - Non-ablative skin resurfacing can include generating electromagnetic radiation having a wavelength of about 1920 nm to about 1950 nm and a fluence of about 3 J/cm | 03-21-2013 |
Patent application number | Description | Published |
20110312995 | BRIDGED AND FUSED HETEROCYCLIC ANTIDIABETIC COMPOUNDS - This invention provides for certain bridged and fused heterocyclic compounds of the formula (I) or a pharmaceutically acceptable salt, ester solvate or prodrug thereof wherein: L is: (II) and the other variables are defined herein; the inventive compounds are agonists of the G-protein coupled receptor 40 (GPR40, also known as free fatty acid receptor FFAR). This invention further relates to pharmaceutical compositions containing these compounds, and the use of these compounds to regulate insulin levels in a mammal. The compounds may be used, for example in the prevention and treatment of Type 2 diabetes mellitus and in the prevention and treatment of conditions related to Type 2 diabetes mellitus, such as insulin resistance, obesity and lipid disorders. | 12-22-2011 |
20110313008 | PENTAFLUOROSULPHOLANE-CONTAINING ANTIDIABETIC COMPOUNDS - This invention provides for certain pentafluorosulpholane-containing compounds of the formula or a pharmaceutically acceptable salt, ester, solvate or prodrug thereof, wherein the variables are defined herein; the inventive compounds are agonists of the G-protein coupled receptor 40 (GPR40, also known as free fatty acid receptor FFAR). This invention further relates to pharmaceutical compositions containing these compounds, and the use of these compounds to regulate insulin levels in a mammal. The compounds may be used, for example in the prevention and treatment of Type 2 diabetes mellitus and in the prevention and treatment of conditions related to Type 2 diabetes mellitus, such as insulin resistance, obesity and lipid disorders. | 12-22-2011 |
Patent application number | Description | Published |
20080299100 | Topical Co-Enzyme Q10 Formulations and Methods of Use - Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 12-04-2008 |
20100062048 | TOPICAL CO-ENZYME Q10 FORMULATIONS AND TREATMENT OF PAIN, FATIGUE AND WOUNDS - CoQ1O has a stimulatory effect on fibroblasts and keratinocytes, increases ATP production, decreases pain. The formulations are useful for promoting acute wound healing, fatigue and treatment of acute and chronic pain. | 03-11-2010 |
20120164215 | TOPICAL CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE - Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 06-28-2012 |
20120201801 | TOPICAL CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE - Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 08-09-2012 |
20130189237 | CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE - Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 07-25-2013 |
20140255372 | CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE - Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 09-11-2014 |